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Analysis of mouse glomerular podocyte mRNA by single-cell reverse
transcription-polymerase chain reaction. Selective investigation of glo-
merular podocytes is not possible using conventional methods in vivo.
Analysis of glomerular epithelium-derived cells in culture yields dubious
results because of the rapid dedifferentiation of podocytes. We developed
a modification of the polymerase chain reaction (PCR) method previously
used to analyze cultured neurons. Podocytes harvested from freshly
dissected glomeruli are ideal target cells for this modified, single cell
reverse transcription-PCR method to reproducibly identify specific
mRNA species from resident intact podocytes in vivo.
Podocytes or glomerular visceral epithelial cells play an impor-
tant role in the physiology and pathophysiology of the glomerulus.
However, the molecular programs governing, for example, the
regulation of the filtration barrier, the turnover of the glomerular
basement membrane and the support of the capillary tuft are
largely unknown. Many systems have been established to study the
cellular functions of podocytes including whole-animal experi-
ments, transfilter organ culture systems, kidney cortex slices in
culture and isolated glomeruli [1]. However, these preparations
also contain other glomerular, or renal cell types, and selective
investigation of podocytes is not possible using these systems. To
date, the selective analysis of glomerular epithelium-derived cells
was only possible in cell culture, but rapid dedifferentiation of
podocytes in vitro leads to serious doubts about the validity of
results obtained with podocytes in culture [2]. As a consequence
of these technical limitations our understanding of the podocyte’s
cell biology remains inadequate, and alternative approaches for
study have to be sought. An in vivo single-cell analysis would be
ideal under these circumstances.
The amount of RNA in a single cell is estimated to be 0.1 to 1
pg and, as such, is difficult to handle experimentally. A modifica-
tion of the most commonly employed nucleic acid amplification
procedure, the polymerase chain reaction (PCR), was used by
Lambolez et al for single-cell reverse transcription-PCR (RT-
PCR) analysis of cultured neurons [3, 4]. This method can only be
applied to tissue that allows access to single cells [5, 6]. The
unique glomerular anatomy where the podocytes reside on the
outside of the glomerular basement membrane (GBM) and are
freely accessible in cortical preparations, makes this cell type an
ideal target for single-cell RT-PCR. Podocytes can be aspirated
selectively under visual control with a micropipette preventing any
contamination from nearby tissue. We show here, for the first
time, the application of a modified single-cell RT-PCR method to
reproducibly identify specific mRNA species from resident, intact,
podocytes in vivo. We chose podocyte-specific genes with poten-
tial functions in glomerular diseases, namely, glomerular epithe-
lial protein 1 (GLEPP1), a receptor-like membrane protein
tyrosine phosphatase [7], vascular endothelial growth factor
(VEGF), a dimeric glycoprotein exerting a proliferative effect on
endothelial cells and increasing vascular permeability [8], and
Wilm’s tumor protein 1 (WT1), a podocyte-specific transcription
factor [9].
METHODS
Preparation and isolation of glomeruli
CD-1 mouse kidneys were rapidly removed after sacrifice.
Following isolation, cortical tissue was minced to a fine paste and
10 to 20 glomeruli free of Bowman’s capsule were transferred to
a 35 mm well and incubated for 15 minutes at 37°C in a solution
containing 0.1 mM dithiothreitol (Life Technologies, Eggenstein,
Germany), 0.6 U/ml RNase inhibitor (Promega, Ingelheim, Ger-
many) and 5 mU neuraminidase Type III from vibrio cholerae
(Sigma, Deisenhofen, Germany). Neuraminidase was used to
remove alpha 2–6-linked sialic acids from the podocytic glycopro-
teins [10] allowing release of podocytes from the GBM and
neighboring podocytes.
Harvesting of single podocytes and reverse transcription
Micropipettes were obtained by pulling 1.5 mm borosilicate
glass pipettes to an aperture diameter of ;5 mm with a micro-
processor-driven DMZ puller (Zeitz, Augsburg, Germany) and
heated at 220°C for five hours to destroy any RNase. All solutions
were treated with 0.1% diethyl-pyrocarbonate (Fluka, Deisen-
hofen, Germany) and autoclaved.
A glomerulus was fixed via a holding-pipette on the plate of an
inverted microscope equipped with DIC optics (Zeiss,
Oberkochen, Germany) and the well was perfused (130 mM NaCl,
5 mM KCl, 4 mM MgCl2, 1 mM EGTA, 5 mM HEPES, pH 7.4) at
a flow rate of 1 ml/min. Micropipettes were filled with ;8 ml
buffer solution (135 mM KCl, 4 mM MgCl2, 1 mM EGTA, 5 mM
HEPES, pH 7.4) and mounted on a WR-88 water hydraulic
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micromanipulator (Narishige, Tokyo, Japan). A 15-minute initial
superfusion period was performed to wash out neuraminidase and
to remove contaminating cells. Single podocytes were then selec-
tively harvested by aspiration of the cell into the micropipette and
the content was then expelled into siliconized tubes containing
0.25 ml Microcarriery Gel-TR (Molecular Research Center,
Cincinnati, OH, USA), 1 ml dithiothreitol (0.1 mM), 0.1 ml 5X
single strand buffer (all Life Technologies), 1 ml random hex-
anucleotide primer (Boehringer Mannheim, Mannheim, Germa-
ny), 0.5 ml dNTP mixture (25 mM each), 0.5 ml RNase inhibitor (40
U/ml) (both from Promega). After one freeze-thaw cycle to
rupture the cytoplasmic membranes, 0.5 ml of SuperScriptRTy
(200 U/ml; Life Technologies) was added and the final volume of
approximately 10 ml was allowed to reverse transcribe for one
hour at 37°C (Fig. 1).
Oligonucleotide primer selection and optimization of the
polymerase chain reaction conditions
The sequence-specific oligonucleotide primers (Life Technolo-
gies) (Table 1) were chosen to include intronic sequences and to
generate PCR products of 200 to 400 bp in length. To identify the
Fig. 1. Scheme of experimental protocol. (A) Photomicrographs demonstrating the podocyte aspiration technique. (1) Micropipette approaching a
freshly dissected glomerulus. (2) Single podocyte is aspirated by negative pressure applied to the interior of the micropipette and the cell soma is clearly
visible inside the very tip of the pipette (arrow). (3) The pipette containing the podocyte is moved upward under continuous suction, (4) thus disrupting
the major processes (bar indicates 10 mm). (B) RNAs harvested from single podocytes are reverse transcribed and amplified by polymerase chain
reaction (PCR).
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most efficient primer pair, different combinations were tested by
serial dilution of mouse cortex cDNA. Polymerase chain reaction
conditions were optimized for MgCl2 concentration and annealing
temperature. Those primer pair combinations that gave, after
optimization, PCR products with single glomeruli (sample pro-
cessing as for single podocytes) were used for single-cell PCR.
Polymerase chain reaction-amplification and product detection
Fifty microliters of PCR-reactions contained: 3 to 8 ml tran-
scribed cDNA, 103 PCR-buffer, 2.5 U AmpliTaq Goldy (both
from Perkin Elmer, Weiterstadt, Germany), and sense and anti-
sense primers (10 pmol). Samples were incubated for 10 minutes
at 94°C to activate AmpliTaq Goldy polymerase [11], followed by
45 to 50 cycles of 45 seconds at 94°C, one minute at 56 to 60°C and
one minute at 72°C and a final extension at 72°C for seven minutes
using a Perkin Elmer 9600 Thermal Cycler. The amplified cDNA
was analyzed on a non-denaturing 5% polyacrylamide gel, stained
with VistraGreeny (Amersham, Braunschweig, Germany) and
visualized with ImageQuant Software on a Storm Fluorophospho-
rimager (both Molecular Dynamics, Krefeld, Germany). To in-
crease sensitivity, in some instances purified PCR-product from
the first PCR was amplified in a second round (40 cycles; same
conditions as above, except with the addition of 1.25 mM dNTP)
with nested primers.
Exclusion of contamination and control for specificity
To control for amplification of non-podocyte derived cDNA we
took several precautions (separate rooms for isolation and ampli-
fication, designated reaction solutions and pipettes, gloves) as
previously described [12]. In addition, at least after every third
podocyte, samples were taken from the medium next to the
glomerulus to exclude contamination of the solution bathing the
glomerulus and were processed as sham cells. The podocyte origin
of the material was confirmed by detection of mRNA for podocyte
specific markers, including GLEPP1, WT1, and VEGF and exclu-
sion of von Willebrand factor (vWF), a marker for endothelial
cells. As control for the cDNA yield, RT-PCR amplification of the
housekeeping gene b-actin was performed with a 3 ml aliquot of
the RT mix. Finally, negative controls consisting of the reaction
mixture without cDNA, or cell lysates not reverse transcribed,
were included in all reaction series to exclude contamination of
the PCR mix or amplification of genomic DNA. As an additional
negative control, podocyte specific primers were excluded to
amplify isolated mouse genomic DNA (40 ng corresponding to
genomic DNA of 10,000 cells).
Authenticity of amplified PCR products was verified by cycle
sequencing on an ABI PRISM 377 automated sequencer (Perkin
Elmer).
RESULTS
Harvesting of single podocytes
Single podocytes were obtained from freshly dissected glomer-
uli via a micropipette with negative pressure aspiration (Fig. 1A).
The pretreatment with neuraminidase allowed a rapid and effi-
cient harvesting of 10 to 15 podocytes per hour. It was not feasible
to pick podocytes without prior short neuraminidase treatment
due to strong adhesion to the GBM.
Amplification of podocyte genes
In total, 109 cDNA samples from single podocytes were ana-
lyzed for different templates. The yield and reproducibility of
mRNA amplification are summarized in Table 2.
b-actin
The housekeeping gene b-actin served as a control for the yield
of cytoplasmatic RNA samples from single podocytes. For the
high copy gene b-actin 68% of analyzed cells (N 5 19) showed a
specific PCR product (Fig. 2A).












S1 CAGATCCGCCTCATCGAGAA 381-400 583 U27810
AS1 CTCTTGATCTCATCAGAGGC 945-964
S2 AAGGAGTTCGTGGAGGAGGT 663-682 272
AS2 GTGACCATGTAGACCAGGTT 915-934
b-actin
S TGTTACCAACTGGGACGACA 147-166 392 M12481
AS TCTCAGCTGTGGTGGTGAAG 519-538
VEGF
S CAGGCTGCTGTAACGATGAA 334-353 207 M95200
AS AATGCTTTCTCCGCTCTGAA 521-540
WT1
S ATCTGAAGACCCACACCAGG 1667-1686 257 M55512
AS TTTGAAAGGTGAGTGGGAGG 1904-1923
muGLEPP1
S TAGACACTTCCGGATCAACTA 1181-1201 351 U37465
AS ATCAGCTGGCACACACTGATG 1512-1531
Abbreviations are: sense (S) and antisense (AS) primer pairs specific for
von Willebrand factor (vWF), b-actin, vascular endothelial growth factor
(VEGF), Wilm’s tumor protein 1 (WT1) and the putative mouse homo-
logue of glomerular epithelial protein 1 (muGLEPP1).
Nucleotide numbers refer to positions within the published sequence.
Table 2. Yield of positive results per number of podocytes and media
controls analyzed in three different series of experiments
Podocytes positive
for mRNA Medial controls
Positive/total % Positive/total %
WT1 3/10 30 0/4 0
1/11 9 0/4 0
5/11 45 0/4 0
VEGF 4/4 100 0/2 0
3/6 50 0/2 0
3/5 60 0/2 0
muGLEPP1 7/9 78 0/4 0
3/6 50 0/3 0
6/13 46 0/4 0
vWFa 0/5 0 0/2 0
0/5 0 0/2 0
0/5 0 0/1 0
b-actin 4/6 66 0/3 0
9/13 69 0/4 0
Abbreviations are in Table 1.
a After two PCR rounds with nested technique (see Methods section)
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Vascular endothelial growth factor
The main product of VEGF amplification consisted of 207 bp
and was detected in 67% of 15 podocytes analyzed. In addition, a
second 279 bp product was occasionally (29%) observed (Fig. 2B).
The two transcripts were subcloned and sequenced. The 207 bp
product was identical with the 260 to 466 nucleotide of mouse
alternatively spliced VEGF165. The sequence of the 279 bp PCR
product had additional 72 nucleotides and corresponds to the
VEGF189 splice isoform [13].
Glomerular epithelial protein 1
A total of 57% of the reverse transcribed samples were positive
for GLEPP1 (N 5 28, Fig. 2D). Because a mouse cDNA sequence
is not available, PCR primers were chosen to have 100% sequence
identity with human, rabbit and the mouse protein tyrosine
phosphatase phi, the putative mouse GLEPP1 (muGLEPP1).
Upon sequencing, the unique muGLEPP1 PCR product obtained
from single podocytes had an 86% identity to the reported rabbit
and 88% to the reported human sequence of GLEPP1, respec-
tively [14].
Wilm’s tumor protein 1
For the transcription factor WT1, which is expressed only in
podocytes of adult kidneys, 28% of podocytes were positive (N 5
32, Fig. 2C).
Controls for specificity
Controls were performed to exclude contamination of mRNA
release into the superfusion medium during podocyte harvesting
or contaminants present on/in the micropipette or amplification
of genomic DNA. Overall, a total of 41 media controls were
analyzed and did not show any PCR product (Table 2). The
non-reverse transcribed samples (N 5 6) were negative when
amplified with podocyte-specific primers. In addition, these
primer pairs were unable to amplify a single template of the
expected length from genomic DNA.
To exclude contamination with endothelial cells, PCR for the
vWF was performed and was consistently negative (N 5 15).
However, in samples containing endothelial cells, primers for
vWF allowed the detection in a 1:10 diluted cDNA from a single
glomerulus and in a single capillary loop removed by pipette from
isolated glomeruli, which may correspond to some 10 endothelial
cells.
Reproducibility of mRNA detection
We were able to obtain amplification products reproducibly
from a single podocyte divided into two equal aliquots (Table 3).
This allowed us to assess the efficiency of cytoplasma harvesting
and reverse transcription by amplification of a housekeeping gene
in one of the two cDNA aliquots. Furthermore, we did not
Fig. 2. Representative RT-PCR analysis of transcripts of single podocytes. Acrylamide gel showing the b-actin (A), VEGF (B), WT1 (C) and
muGLEPP1 (D) products amplified by single-cell RT-PCR. Data from 6 to 7 podocytes and 2 to 3 media controls are shown. Note that two PCR
products were obtained for VEGF. In addition to the expected 207 bp product (corresponding to VEGF165), a further splice variant containing 72 bp
(corresponding to VEGF189) was amplified (lane #5 and #10). (M) is the molecular weight marker.
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observe a tendency for product yield to decline with increasing
time (Table 3).
DISCUSSION
In this study we have developed a novel application of single-
cell RT-PCR to analyze podocyte-specific mRNA in single podo-
cytes obtained by microaspiration from glomeruli. Aliquoting the
cDNA following reverse transcription allows analysis of multiple
mRNA species from a single cell. Single-cell RT-PCR provides a
rapid tool to evaluate the in vivo mRNA content of podocytes and,
thus, represents the first method allowing determination of podo-
cyte-specific gene expression without prior cell culture.
As a consequence of the unique glomerular anatomy, podocytes
are optimally accessible to single cell aspiration after removal of
the Bowman’s capsule. Podocytes are confined to the outside of
the very robust GBM and the membrane effectively prevents
contamination of the aspirate with endothelial or mesangial cells.
We have investigated two procedures for the isolation of
mRNA from a single cell. We prefer total cell approach to cytosol
aspiration, as single cell aspiration allows high yield and rapid
sampling of multiple podocytes from one glomerulus. In our
hands, it was not possible in the limited time span available for
mRNA analysis to obtain a significant number of membrane giga
ohm seals required for cytosol aspiration by the patch clamp
pipette. The strong anchoring of podocytes in the GBM made it
impossible to obtain cells from glomeruli without pretreatment.
Only after reducing podocyte-GBM contacts, by treatment with
neuraminidase [10], were we able to easily harvest multiple
podocytes over a short (60 to 90 min) time period. Because the
nucleus is harvested with total cell aspiration, the possibility of
amplification of genomic DNA needs to be excluded. While
Johansen et al [15] have shown that genomic sequences are not
amplified by single-cell RT-PCR, we, nevertheless, excluded this
by omission of reverse transcriptase and by including genes with
known genomic structure [6].
Due to its high sensitivity, single-cell RT-PCR is particularly
vulnerable to low levels of contamination resulting in false-
positive amplification reactions. It is critically important to have
several controls in place to detect these artifacts [6]. In fact, over
1/3 of the samples analyzed in this study were negative controls.
In this study different cDNA templates could be amplified from
single podocytes. The housekeeping gene b-actin served as a
control for the mRNA yield and efficiency of reverse transcrip-
tion. This internal control gene was detected in 2/3 of the samples.
WT1, GLEPP1 and VEGF were chosen as markers for podocyte-
specific mRNAs. The transcription factor WT1 is expressed
exclusively in the glomerular podocytes in the adult kidney [9].
GLEPP1 is a receptor-like transmembrane protein tyrosine phos-
phatase located on the apical surface of podocytes, the expression
of which is reduced in human glomerular disease [7]. VEGF has
been reported previously to be expressed by human glomerular
epithelial cells in vivo [16]. While one report also found VEGF
expression in cultured bovine glomerular cells [17], this has not
been reported in vivo. In addition, VEGF has been implicated as
playing a role in glomerular disease [8]. Using the approach
described here, it was possible for the first time to detect known
splice variants of VEGF [13, 16] at the single podocyte level.
The sensitivity limits of podocyte single cell RT-PCR is not yet
known. However, testing different primer pair combinations
together with careful optimization of the conditions used enabled
us to detect the presumably low-level expressed transcription
factor WT-1 in 1/3 of all samples examined.
Semiquantification of single-cell RT-PCR is not possible to
achieve by standard techniques [6, 12]. For semiquantification a
practical approach is to rely on an ubiquitously expressed high
copy number housekeeping gene as an internal standard for
effective reverse transcription and PCR amplification. The gene
of interest can then be related as a percentage of the cDNA
positive for the housekeeping gene. This method has proven to be
quite effective in semiquantification of neuronal MHC class I
molecules [4].
In conclusion, mRNA of podocytes harvested from intact
glomeruli can be evaluated at the single-cell level. Especially when
combined with immunohistology and in situ hybridization, this
method should prove advantageous to investigate patterns of gene
expression and elucidate the roles of specific genes in podocyte
function in health and disease.
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Time min 0 4 14 17 21 24 30 34 37 41 44 50 61 66 69 78 82 87
muGLEPP1 2 2 1 1 2 2 1 1 2 2 2 2 2 1 2 1 2 2
b-actin 1 2 1 1 2 2 1 1 2 2 2 1 2 2 2 1 1 1
Individual podocytes (P), each given a sequential number, were harvested from one isolated glomerulus at the times indicated. Media controls (M)
from the superfusion solution next to the glomerulus were taken in parallel at the times indicated. Each sample was divided in two, one being amplified
with primers for glomerular epithelial protein 1 (muGLEPP1) and the other for b-actin.
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